- Home
- PRTC vs BME Comparison
PRTC vs BME Comparison
Compare PRTC & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- BME
- Stock Information
- Founded
- PRTC 2015
- BME 2005
- Country
- PRTC United States
- BME United States
- Employees
- PRTC N/A
- BME N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- BME Trusts Except Educational Religious and Charitable
- Sector
- PRTC Health Care
- BME Finance
- Exchange
- PRTC Nasdaq
- BME Nasdaq
- Market Cap
- PRTC 402.3M
- BME 462.3M
- IPO Year
- PRTC N/A
- BME N/A
- Fundamental
- Price
- PRTC $16.74
- BME $36.00
- Analyst Decision
- PRTC Buy
- BME
- Analyst Count
- PRTC 1
- BME 0
- Target Price
- PRTC $45.00
- BME N/A
- AVG Volume (30 Days)
- PRTC 11.0K
- BME 34.0K
- Earning Date
- PRTC 04-28-2025
- BME 01-01-0001
- Dividend Yield
- PRTC N/A
- BME 6.26%
- EPS Growth
- PRTC N/A
- BME N/A
- EPS
- PRTC N/A
- BME 1.44
- Revenue
- PRTC $468,000.00
- BME N/A
- Revenue This Year
- PRTC N/A
- BME N/A
- Revenue Next Year
- PRTC $160.00
- BME N/A
- P/E Ratio
- PRTC N/A
- BME $28.37
- Revenue Growth
- PRTC N/A
- BME N/A
- 52 Week Low
- PRTC $13.30
- BME $35.53
- 52 Week High
- PRTC $32.98
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- PRTC 47.62
- BME 39.05
- Support Level
- PRTC $13.30
- BME $35.78
- Resistance Level
- PRTC $16.75
- BME $36.65
- Average True Range (ATR)
- PRTC 0.98
- BME 1.11
- MACD
- PRTC -0.03
- BME -0.03
- Stochastic Oscillator
- PRTC 51.39
- BME 38.72
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.